1
|
Kiselev AR, Posnenkova OM, Belova OA, Romanchuk SV, Popova YV, Prokhorov MD, Gridnev VI. Impact of Clinical Factors on the Achievement of Target Blood Pressure in Hypertensive Patients from Ivanovo Region of Russia: Data of 2015. High Blood Press Cardiovasc Prev 2017; 24:425-435. [PMID: 28856581 DOI: 10.1007/s40292-017-0227-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2017] [Accepted: 08/14/2017] [Indexed: 12/26/2022] Open
Abstract
INTRODUCTION In Russia, blood pressure (BP) control is below the optimal. The little is known about regional features and barriers to adequate BP control in Russian primary care. AIM To evaluate the impact of clinical factors on achieving the target BP in hypertensive patients in one region of Russia. METHODS Retrospective medical data of 2015 on 11,129 patients (31.4% male) with hypertension (Htn) from Ivanovo region of Russia were examined. Achievement of target BP was assessed in all patients. We study association between BP control and clinical factors. RESULTS 45.9% of studied patients with Htn had controlled BP. The frequency of achieving the target BP in subsets of hypertensive patients was 37.8% in patients with diabetes, 39.5% in patients with coronary artery disease, and 29.9% in patients with chronic heart failure. The main clinical factors associated with achieving the target BP in studied hypertensive patients were the advice on alcohol consumption, advice on smoking cessation, and advice on weight reduction. Therapy with main antihypertensive drugs (in particular, beta-blockers and thiazide diuretics) were also factors of optimal BP control in these patients. Comorbidities (chronic heart failure and cardiovascular diseases requiring the prescription of aspirin and statins) and family history of coronary artery disease were associated with inadequate BP control. A negative effect of some antihypertensive drugs (potassium sparing diuretics, ARBs, ACE-Is, and dihydropyridine CCBs) on BP control that was found out in our study requires further investigation. Other studied factors had no influence on BP control in patients with Htn from Ivanovo region. CONCLUSION We identified regional factors of BP control in hypertensive patients from Ivanovo region of Russia. It is shown that individual medical education (in particular, medical advices) is the most important factor of optimal BP control. The intervention with antihypertensive therapy (beta-blockers and thiazide diuretics) facilitates the achievement of target BP. Comorbidity and age reduce the frequency of achieving the target BP.
Collapse
Affiliation(s)
- A R Kiselev
- Research Institute of Cardiology, Saratov State Medical University n.a. V.I. Razumovsky, 112, Bolshaya Kazachya str., Saratov, 410012, Russia.
| | - O M Posnenkova
- Research Institute of Cardiology, Saratov State Medical University n.a. V.I. Razumovsky, 112, Bolshaya Kazachya str., Saratov, 410012, Russia
| | - O A Belova
- Ivanovo Regional Cardiology Dispensary, Ivanovo, Russia
| | - S V Romanchuk
- Healthcare Department of Ivanovo Region, Ivanovo, Russia
| | - Y V Popova
- Research Institute of Cardiology, Saratov State Medical University n.a. V.I. Razumovsky, 112, Bolshaya Kazachya str., Saratov, 410012, Russia
| | - M D Prokhorov
- Saratov Branch of the Institute of Radio Engineering and Electronics of Russian Academy of Sciences, Moscow, Russia
| | - V I Gridnev
- Research Institute of Cardiology, Saratov State Medical University n.a. V.I. Razumovsky, 112, Bolshaya Kazachya str., Saratov, 410012, Russia
| |
Collapse
|
4
|
Roas S, Bernhart F, Schwarz M, Kaiser W, Noll G. Antihypertensive combination therapy in primary care offices: results of a cross-sectional survey in Switzerland. Int J Gen Med 2014; 7:549-56. [PMID: 25525383 PMCID: PMC4267521 DOI: 10.2147/ijgm.s74023] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND Most hypertensive patients need more than one substance to reach their target blood pressure (BP). Several clinical studies indicate the high efficacy of antihypertensive combinations, and recent guidelines recommend them in some situations even as initial therapies. In general practice they seem widespread, but only limited data are available on their effectiveness under the conditions of everyday life. The objectives of this survey among Swiss primary care physicians treating hypertensive patients were: to know the frequency of application of different treatment modalities (monotherapies, free individual combinations, single-pill combinations); to see whether there are relationships between prescribed treatment modalities and patient characteristics, especially age, treatment duration, and comorbidities; and to determine the response rate (percentage of patients reaching target BP) of different treatment modalities under the conditions of daily practice. METHODS This cross-sectional, observational survey among 228 randomly chosen Swiss primary care physicians analyzed data for 3,888 consecutive hypertensive patients collected at one single consultation. RESULTS In this survey, 31.9% of patients received monotherapy, 41.2% two substances, 20.9% three substances, and 4.7% more than three substances. By combination mode, 34.9% took free individual combinations and 30.0% took fixed-dose single-pill combinations. Combinations were more frequently given to older patients with a long history of hypertension and/or comorbidities. In total, 67.8% of patients achieved their BP target according to their physician's judgment. When compared, single-pill combinations were associated with a higher percentage of patients achieving target BP than free individual combinations and monotherapies for the total sample and for patients with comorbidity. CONCLUSION Antihypertensive combination therapy was widely used in Swiss primary care practices. The number of prescribed substances depended on age, treatment duration, and type and number of comorbidities. Although the response rate was generally modest under the conditions of daily practice, it was higher for single-pill combinations than for monotherapies and free individual combinations. Further studies are needed to confirm these observations.
Collapse
Affiliation(s)
- Susanne Roas
- Department of Internal Medicine, University Hospital, Zurich, Switzerland
| | | | | | | | - Georg Noll
- HerzKlinik Hirslanden, Zurich, Switzerland
| |
Collapse
|
5
|
Boytsov SA, Balanova YA, Shalnova SA, Deev AD, Artamonova GV, Gatagonova TM, Duplyakov DV, Efanov AY, Zhernakova YV, Konradi AO, Libis RA, Minakov AV, Nedogoda SV, Oshchepkova EV, Romanchuk SA, Rotar OP, Trubacheva IA, Chazova IE, Shlyakhto EV, Muromtseva GA, Evstifeeva SE, Kapustina AV, Konstantinov VV, Oganov RG, Mamedov MN, Baranova EI, Nazarova OA, Shutemova OA, Furmenko GI, Babenko NI, Azarin OG, Bondartsov LV, Khvostikova AE, Ledyaeva AA, Chumachek EV, Isaeva EN, Basyrova IR, Kondratenko VY, Lopina EA, Safonova DV, Skripchenko AE, Indukaeva EV, Cherkass NV, Maksimov SA, Danilchenko YV, Mulerova TA, Shalaev SV, Medvedeva IV, Shava VG, Storozhok MA, Tolparov GV, Astakhova ZT, Toguzova ZA, Kaveshnikov VS, Karpov RS, Serebryakova VN. ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD: PREVALENCE, AWARENESS, TREATMENT AND CONTROL. BY THE DATA FROM ECCD. ACTA ACUST UNITED AC 2014. [DOI: 10.15829/1728-8800-2014-4-4-14] [Citation(s) in RCA: 132] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Aim. To study prevalence of arterial hypertension (AH), mean values of systolic and diastolic blood pressure (SBP, DBP), awareness of patients about their disease, medication consumption (MC) and efficacy of treatment in several regions of Russia.Material and methods. Representative selections were made in 9 regions of Russia: men (n=5563), women (n=9737) of 25–64 y.o., studied in 2012–2013 with the response 80%. Systematic stratified multilevel random selection was formed with localilty criteria (Kisch method). The Questionnaire on the presence of AH included: awareness of the patient about his disease, drug intake. BP measurement was performed on the right arm by automatic tonometer Omron in sitting position after 5 minutes resting. The mean value of two measurements was used. BP defined as SBP ≥140 mmHg, DBP ≥90 mmHg, or if the patient had taken antihypertensive therapy. Efficacy of treatment — the part of patients (in %) who reached target BP. Control group — part of patients (in %) with BP <140/90 mmHg. Statistic data calculation was done with computer-based statistic software — SAS with standardising by age stratification of Europe.Results. Mean SBP and DBP were 130,7±0,1 mmHg and 81,6±0,1 mmHg respectively. Prevalence of AH — 44%, higher in men (p<0,001). Prevalence of AH was higher in rural area citizens in men — 51,8% vs 47,5% (р<0,02) and in women — 42,9% vs 40,2% (р<0,05). Awareness was 67,5% in men, 78,9% in women. Medications were taken by 60,9% of women and 39,5% of men. Effectively treated were 53,5% of women and 41,4% of men. With the age the part of effectively treated decreases (p<0,0005). BP is under control only in 1/3 of women and 14,4% of men.Conclusion. The role of AH as one of the main modifiable risk factors of cardiovascular diseases is proved, however it is depressing that the percent of controlled AH is low. BP control is the main task of outpatient surveillance at every local outpatient department, where now less than a half of those affected are being observed.
Collapse
Affiliation(s)
- S. A. Boytsov
- FSBI State Scientific-Research Centre for Preventive Medicine of the Ministry of Health, Moscow
| | - Yu. A. Balanova
- FSBI State Scientific-Research Centre for Preventive Medicine of the Ministry of Health, Moscow
| | - S. A. Shalnova
- FSBI State Scientific-Research Centre for Preventive Medicine of the Ministry of Health, Moscow
| | - A. D. Deev
- FSBI State Scientific-Research Centre for Preventive Medicine of the Ministry of Health, Moscow
| | - G. V. Artamonova
- FSBI Scientific-Research Institute for Complex Cardiovascular Problems of SD RAMS, Kemerovo
| | | | - D. V. Duplyakov
- SBHI Samara Region Clinical Cardiological Dispensary, Samara
| | | | - Yu. V. Zhernakova
- FSBI Russian Cardiologic Scientific-Production Complex of the Ministry of Helath, Moscow
| | - A. O. Konradi
- FSBI The Almazov Medical Research Centre, Saint-Petersburg
| | - R. A. Libis
- SBEI HPE Orenburg State Medical Academy, Orenburg
| | | | | | - E. V. Oshchepkova
- FSBI Russian Cardiologic Scientific-Production Complex of the Ministry of Helath, Moscow
| | | | - O. P. Rotar
- FSBI The Almazov Medical Research Centre, Saint-Petersburg
| | | | - I. E. Chazova
- FSBI Russian Cardiologic Scientific-Production Complex of the Ministry of Helath, Moscow
| | | | - G. A. Muromtseva
- FSBI State Scientific-Research Centre for Preventive Medicine of the Ministry of Health
| | - S. E. Evstifeeva
- FSBI State Scientific-Research Centre for Preventive Medicine of the Ministry of Health
| | - A. V. Kapustina
- FSBI State Scientific-Research Centre for Preventive Medicine of the Ministry of Health
| | - V. V. Konstantinov
- FSBI State Scientific-Research Centre for Preventive Medicine of the Ministry of Health
| | - R. G. Oganov
- FSBI State Scientific-Research Centre for Preventive Medicine of the Ministry of Health
| | - M. N. Mamedov
- FSBI State Scientific-Research Centre for Preventive Medicine of the Ministry of Health
| | - E. I. Baranova
- Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - A. E. Skripchenko
- FSBI Scientific-Research Institute for Complex Cardiovascular Problems of SD RAMS
| | - E. V. Indukaeva
- FSBI Scientific-Research Institute for Complex Cardiovascular Problems of SD RAMS
| | - N. V. Cherkass
- FSBI Scientific-Research Institute for Complex Cardiovascular Problems of SD RAMS
| | - S. A. Maksimov
- FSBI Scientific-Research Institute for Complex Cardiovascular Problems of SD RAMS
| | - Ya. V. Danilchenko
- FSBI Scientific-Research Institute for Complex Cardiovascular Problems of SD RAMS
| | - T. A. Mulerova
- FSBI Scientific-Research Institute for Complex Cardiovascular Problems of SD RAMS
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Chronic kidney disease in general populations and primary care: diagnostic and therapeutic considerations. Curr Opin Nephrol Hypertens 2014; 22:593-8. [PMID: 24104481 DOI: 10.1097/mnh.0b013e328365adf6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
PURPOSE OF REVIEW The majority of people with chronic kidney disease (CKD) are managed by primary care physicians and nurses, but much of the initial research on CKD care was based in secondary care. The purpose of this article is to review the important recent studies of CKD in primary care that are starting to provide an evidence base for the strategies to improve the management and outcomes of the unreferred majority of people with CKD. RECENT FINDINGS People with CKD in primary care populations differ substantially from those familiar to nephrologists in secondary care by being older, having less reduction in glomerular filtration rate (GFR) and lower prevalence of proteinuria. These differences have important implications for management priorities. Detailed studies have identified widespread deficiencies in the care of patients with CKD in primary care (though these are also reported in secondary care). Interventions that may improve performance include automated reporting of estimated GFR, incentivizing primary care practitioners to achieve therapeutic goals and quality improvement strategies such as audit-based education. SUMMARY Studies have identified a need for improved management of CKD in primary care as well as methods to achieve this. Future studies should focus on the promotion of self-management through telemedicine and the Internet.
Collapse
|